List of insiders holdings for LEXICON PHARMACEUTICALS INC.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Invus Public Equities L.P. Artal Treasury Ltd Invus L.P. Invus Public Equities Advisors LLC Invus Advisors L.L.C. Director 10% Owner | 2024-03-13 21:20:27 | 117,553,284 0 | 117,553,284 | Form 13D |
| Artal International S.C.A. Minne Pascal Artal International Management S.A. Artal Group S.A. Westend S.A. Stichting Administratiekantoor Westend Director 10% Owner | 2020-12-17 14:43:18 | 0 71,178,364 | 71,178,364 | Form 4 |
| DEBBANE RAYMOND Director | 2023-10-12 16:01:18 | 1,340,847 5,451,204 | 6,792,051 | Form 4 |
| MCNAIR ROBERT C 10% Owner | 2003-08-08 16:21:09 | 5,949,400 0 | 5,949,400 | Form 13D |
| Invus US Partners LLC Ulys L.L.C. DEBBANE RAYMOND Director 10% Owner | 2022-08-09 16:48:13 | 331,545 5,451,204 | 5,782,749 | Form 4 |
| Invus C.V. Director 10% Owner | 2021-01-05 21:21:12 | 4,321,214 0 | 4,321,214 | Form 4 |
| SANDS ARTHUR T President & CEO | 2014-03-03 18:20:20 | 1,236,579 877,500 | 2,114,079 | Form 4 |
| COATS LONNEL Chief Executive Officer | 2024-02-29 16:26:53 | 1,430,198 0 | 1,430,198 | Form 4 |
| Artal International S.C.A. Wittouck Amaury Artal International Management S.A. Artal Group S.A. Westend S.A. Stichting Administratiekantoor Westend Invus Public Equities L.P. Invus L.P. Invus Public Equities Advisors LLC Invus Advisors L.L.C. Director 10% Owner | 2024-03-13 21:22:49 | 0 1,150,922 | 1,150,922 | Form 4 |
| WADE JEFFREY L President and CFO | 2024-02-29 16:32:30 | 459,714 0 | 459,714 | Form 4 |
| Garner Thomas SVP, Chief Commercial Officer | 2024-02-12 16:14:04 | 454,260 0 | 454,260 | Form 4 |
| ZAMBROWICZ BRIAN P EVP, Chief Scientific Officer | 2014-03-03 18:16:40 | 402,953 0 | 402,953 | Form 4 |
| MAIN ALAN J EVP, Innov & Chem Sciences | 2024-02-29 16:30:47 | 347,198 0 | 347,198 | Form 4 |
| Crum Brian T SVP, General Counsel & Secr. | 2024-02-29 16:27:54 | 270,507 0 | 270,507 | Form 4 |
| Kassler-Taub Kenneth B. SVP, Regulatory & QA | 2024-02-29 16:29:48 | 255,742 0 | 255,742 | Form 4 |
| BROWN PHILIP M SVP, Clinical Development | 2010-02-17 17:12:29 | 253,606 0 | 253,606 | Form 4 |
| BANSAL AJAY EVP Corp Dev and CFO | 2009-06-02 17:44:48 | 250,000 0 | 250,000 | Form 4 |
| Amouyal Philippe Director | 2023-11-14 16:12:48 | 240,332 0 | 240,332 | Form 4 |
| TYLE PRAVEEN EVP, R&D | 2021-03-02 17:00:45 | 204,771 0 | 204,771 | Form 4 |
| RIGGS RANDALL B SVP, Corp Licensing | 2004-02-25 16:13:19 | 192,500 0 | 192,500 | Form 4 |
| SOBECKI CHRISTOPHER J Director | 2023-05-22 16:06:47 | 159,023 0 | 159,023 | Form 4 |
| GREGORY JULIA P EVP and CFO | 2008-02-11 18:05:27 | 150,000 0 | 150,000 | Form 4 |
| Granowitz Craig B SVP, Chief Medical Officer | 2024-02-29 16:28:56 | 147,123 0 | 147,123 | Form 4 |
| McDermott Wendy VP, Human Resources | 2024-02-29 16:31:43 | 127,030 0 | 127,030 | Form 4 |
| Tessmer James F VP, Finance & Accounting | 2021-03-16 19:45:56 | 122,746 0 | 122,746 | Form 4 |
| Seth Kiernan VP, Chief Commercial Officer | 2023-03-01 16:55:29 | 104,350 0 | 104,350 | Form 4 |
| HOWSON TAMAR D EVP of Bus Dev | 2008-02-11 18:05:30 | 100,000 0 | 100,000 | Form 4 |
| Sullivan Diane E. Director | 2023-07-31 08:14:56 | 96,515 0 | 96,515 | Form 4 |
| Alexander Kristen VP, Finance and Accounting | 2024-02-29 16:33:17 | 90,270 0 | 90,270 | Form 4 |
| Lapuerta Pablo EVP and CMO | 2020-04-24 17:02:57 | 85,719 0 | 85,719 | Form 4 |
| Tragash Steven Alan VP, Corporate Affairs | 2010-02-17 18:06:17 | 85,500 0 | 85,500 | Form 4 |
| ISHIMOTO LANCE K SVP, Intellectual Property | 2008-02-11 18:05:33 | 80,000 0 | 80,000 | Form 4 |
| BARKER SAM L Director | 2023-05-22 16:02:55 | 79,617 0 | 79,617 | Form 4 |
| PERSON CHRISTOPHE VP Informatics | 2004-01-13 17:01:48 | 75,900 0 | 75,900 | Form 4 |
| SCHAFER CAROL VP Finance - Communications | 2003-12-10 15:01:46 | 61,000 0 | 61,000 | Form 3 |
| Santini Alexander A EVP and CCO | 2020-04-24 17:12:22 | 55,584 0 | 55,584 | Form 4 |
| PIGGOTT JAMES R PHD SVP of Pharm Bio | 2008-02-11 18:05:40 | 50,000 0 | 50,000 | Form 4 |
| NORTHCOTT JOHN VP, Marketing, Comm Strategy | 2015-03-03 16:08:14 | 41,985 0 | 41,985 | Form 4 |
| NIES ALAN S Director | 2023-05-22 16:05:20 | 41,046 0 | 41,046 | Form 4 |
| Swain Judith L Director | 2023-05-22 16:07:28 | 40,332 0 | 40,332 | Form 4 |
| Palantoni Frank Director | 2023-05-22 16:06:07 | 40,332 0 | 40,332 | Form 4 |
| LEFKOWITZ ROBERT J MD Director | 2023-05-22 16:04:39 | 40,332 0 | 40,332 | Form 4 |
| COLBERT WALTER F SVP, HR and Corp Serv | 2007-02-15 16:40:13 | 40,000 0 | 40,000 | Form 4 |
| ROSE CLAYTON STUART Director | 2007-06-27 16:34:13 | 25,000 0 | 25,000 | Form 4 |
| Mills Barry Director | 2007-04-27 16:35:38 | 10000 0 | 10000 | Form 4 |
| Wiltsey Kathleen M Director | 2009-04-27 16:40:25 | 10000 0 | 10000 | Form 4 |
| CLOHERTY PATRICIA M Director | 2006-04-28 17:58:27 | 10000 0 | 10000 | Form 4 |
| CASKEY C THOMAS Director | 2005-10-17 17:52:09 | 6300 200 | 6500 | Form 4 |